Abstract: A prospective study on predictors of polypharmacy in Geriatrics was conducted in the General Medicine department of a 750 bedded multi-specialty private hospital in South India. A total of 124 geriatric patients were enrolled in the study of which 59% were male patients and 41% were female patients. The analysis of results of the study conducted revealed that 54.73% of population were prescribed with 6-10 drugs, 37.09% with 11-15 drugs and 5.64% with 16-20 drugs. Our study assessed Potentially Inappropriate Medications (PIM) as per Beers Criteria. The results revealed that the PIM use was observed in 48.3% patients. The analysis also revealed that the association between the number of drugs and number of PIM was statistically significant. Similarly the association between the number of co-morbidities and number of drugs was statistically significant.
Introduction
The term polypharmacy refers to the group of medications one person may be taking. It comes from two Greek root words: poly, meaning many, and pharmakeia meaning medicines or drugs. It is generally used when that one person is taking too many medications, or when the drugs have been prescribed by many doctors, and may not have been coordinated well. The definition of polypharmacy is still controversial [1] . One simple definition is based on the total number of different medications a patient takes concurrently. Topical and herbal medications are generally excluded of this definition as they are often not included in the traditional methods of assessing prescription quality.
Polypharmacy is associated with suboptimal and inappropriate prescribing. Many medications that have an increased tendency to cause problems for older patients have been labeled as inappropriate drugs for this segment of the population. The simplest definition of an inappropriate drug is one that has greater potential to harm than to benefit the patient. It is difficult to state that any given drug should not be used in an elderly patient under any circumstances. Highrisk medications do not cause problems in all elderly patients, but they do have an increased potential to cause problems.
Potentially inappropriate use of medications (PIM) use in the elderly places a significant burden on the healthcare system. PIM is defined as use of a drug with risk of an adverse event that outweighs its clinical benefit, particularly when there is a safer or more effective alternative therapy for the same condition. Beers criteria to assess and reduce the risk of PIM in the elderly by identifying PIM have been developed. The criteria was subsequently updated. Utilization of this criteria has shown PIMs to be associated with a 25% increase in the risk of hospitalizations in elderly nursing home residents. Sometimes it is accompanied with lots of hazards due to suboptimal prescribing habits as well as medication management [2] .
Polypharmacy is not sovereign clinical marker to indicate worthy usage of medicines. Clinical outcomes are indicated by the proper diagnosis, dose & type of medication not by number of medicines. Higher the number of medicines, more difficult it would be to find proper medication history, also greater chances of ADR development [3] 
Literature Survey
An extensive literature survey was carried out regarding the different aspects that should be considered while doing a study based on Polypharmacy. These include the various reasons for Polypharmacy, complications & risk factors associated with different classes of drug used, management and clinical significance, self care assessment, etc. The literatures supporting the study were gathered from various journals like American Journal of Health-System Pharmacy, British Medical Journal, Universal Journal of Pharmacy, International Journal of Pharmacy and Pharmaceutical Sciences. The journal search and collection of literatures were done utilizing the facilities of IOWA Drug Information System (IDIS), Micromedex, and Medline and from the Internet
Method
The department selected for the study was the Department of General Medicine.The reason for selection of this department was that, pilot study revealed more prevalence of Geriatric cases in the department of General Medicine. It was also identified that, the Department of General medicine has got lot of potential to use many classes of drugs. Pharmacy practice department provides services to General Medicine Department and a good co-operation from medical team added up to the reason for selecting the department for conducting the study. All the geriatric patients admitted in 
Results & Discussion
The work entitled "Study on prevalence and predictors of polypharmacy in Geriatric Patients at a private corporate hospital" was conducted in the department of general medicine at a 750 bedded multispecialty hospital. During the study 124 patients were enrolled. Prior consent was taken from the patients after explaining them the need of the study.
The analysis of the results of the study revealed that there were 73(59%) male patients and 51(41%) female patients who fit into the inclusion criteria ( fig.1 ). Male population were affected more with polypharmacy which is in accordance with the literatures which documented that males are more prone to polypharmacy because of their social habits. The results were supported by the study conducted by Kumara Swamy RC et al (2014) [4] where it is documented that out of the total 940 prescriptions, 479 (50.95%) patients were male and 461 (49.04%) patients were females.
Figure 1
The patients were categorised according to their body mass index. 13(10.5%) patients were found to be obese, 24 (19.4%) were found to be overweight and 87(70.1%) were having normal body mass index.
Age categorisation ( fig.2 ) of patients revealed that the major fraction 68(54.8%) of patients were of age group 60-69 years old, 42(33.8%) were of age group 70-79, 9(7.2%) were of age group 80-89 while only 4% of the patients were above 90 years of age. The results were comparable with the study conducted by Akshaya B Srikanth et al (2012) [5] were it is documented that major fraction (64.07%) of the patients were in the age group of 19-45 years old, while only 4.85% of the patients were above 70 years of age.
Figure 2
In this study the most common disorder found was hypertension with patients 43(34.6%), Type II diabetes mellitus with 39(31.4%), LRTI with 15(12.09 %) and chronic renal failure with 14(11.2%). Other diagnosis observed were CVA, COPD, IHD, fever, gastritis, tuberculosis, UTI, hypothyroidism, HRAD, IWMI and CAD. The results were supported by the study conducted by Nimmy N John et al (2014) [6] in which it was studied that the most common disorders were hypertension with 27.3%, type II diabetes mellitus with 22.4%, chronic obstructive pulmonary disorder with 18.5% and ischemic heart disease with 15.4%. Other diagnoses observed in our study population are congestive cardiac failure, urinary tract infection, rheumatoid arthritis, cirrhosis and hepatitis.
In the study population the major co-morbidities found were hypertension 52(41.9%), diabetes mellitus 49(39.5%) and CRF 11(7.74%). Other co-morbidities include COPD, tuberculosis, ischemic heart disease, hypothyroidism, CVA, bronchial asthma, CCF, vertigo, trigeminal neuralgia, diabetic retinopathy, migraine, coronary artery disease, lung abscess, left ventricular dysfunction, parkinsonism, rheumatoid arthritis, HIV and interstitial lung disease. Licensed Under Creative Commons Attribution CC BY (2014) [7] documented that more than half (56%)of patients that were most commonly involved in poly-pharmacy, had co-morbidities of high blood pressure, diabetes and dyslipidaemia 23%, 18% and 15% respectively. In our study, the patients were prescribed with 2 to 15 drugs at the time of discharge. The average number of drugs prescribed during discharge was found to be 7.6. It was found that 78.8% of population had been prescribed with 2-6 drugs, 16.03% with 7-10 drugs and 5.17% with 11-15 drugs. In our study, the number of drugs per prescription ranges from 6 drugs to the maximum of 20 drugs. On an average 12 drugs were prescribed per prescription .The mean of drugs given during treatment was found to be 10.35±.2.711.It was found that 60.95% of population had been prescribed with 6-10 drugs, 37.09% with 11-15 drugs and 5.64% with 16-20 drugs. The results were supported by the study conducted by Nimmy N John et al (2013) [8] documented that the population had been prescribed with minimum of 4 drugs to the maximum of 14 drugs. The average number of drugs been prescribed was found to be 9. In their study 18 % of population had been prescribed with 2-4 drugs, 52.18% with more than 5 drugs and 27.52% with 9-12drugs. A very less percentage of the population (1.18%) had been prescribed with more than 12 drugs.
In our study the majority of patients were prescribed with antibiotics (70.16%) followed by proton pump inhibitors (54%), anti-hypertensives(49.1%), anti-emetics (45.1%), anti-diabetics (42.7%), anti-asthmatics (41.9) and H-2 blockers (39.5%). Similar study was conducted by Mahmoud Taleb et al (2014) [9] and the results are comparable. The most common drug groups prescribed were ACE-inhibitors (39.3%), followed by anti-platelets (37.3%), lipid lowering drugs (statins) (31.9%), beta-blockers (18.1), calcium channel blocker (19.2), nitrates (16.1) and diuretics (22.6).
The use of antimicrobials has been studied. The major class of antimicrobials prescribed were beta-lactam antibiotics (64.23%) out of which 22(17.7%) were piperacillin + tazobactam, 17(13.37%) with ceftriaxone, 14(11.2%) with cefotaxime, 13(10.4%) with cefepime + tazobactum, 5(4.03%) with meropenem, 2(1.6%) with cefaperazone + sulbactum, cefuroxime and faropenem; and 1(0.80%) with cefuroxime + clavulanic acid and amoxicillin + clavulanic acid. Other class of antimicrobials include fluoroquinolones (14.4%), macrolides (4.8%), aminoglycosides (4.8%), tetracyclines (0.8%), anti-tubercular drugs (4.83%) and antifungals (4.83%).
The Proton Pump Inhibitors usage in our study was pantoprazole 63(50.8%), esomeprazole 3(2.41%) and rabeprazole 1(0.89%).
The use of insulin and oral anti-diabetic agents was studied .Insulin was given to the major population 38(30.6%). Major oral hypoglycaemic drugs prescribed include metformin 7(5.6%); and combination with sulphonylureas like, glimepride + metformin and gliclazide + metformin 1(0.80%). sulphonylureas like glimepride 3(2.41%) and gliclazide 1(0.80%). Under the class thaizolidnediones, pioglitazone 1(0.80%) was prescribed and under alphaglucosidase inhibitor, voglibose 3(2.41%) was prescribed.
The use of anti-hypertensives was studied. Diuretic usage was 29(23.3%), beta-blockers 9(7.23%), calcium channel blocker 35(28.22%), ACE Inhibitors 4(3.22%), ARBs 10(8.06%) and alpha-blockers 7(5.64%).
Potentially inappropriate medication use was identified with the help of Beer's Criteria. The PIM use was observed in 60(48.3%) patients and patients without PIM use was 64(51.7%).One, two, three and four PIMs were received by 31, 17,8 and 2 patients respectively(table 1,fig 3) .This result is supported by a similar study conducted by Parthasarathi G et al(2011) [10] which documented that PIM use was observed both at admission and during hospital stay in 9(1.1%) patients & One,two and three PIMs were received by 134, 46 and 11 patients respectively.
As per the assessment done, aspirin 28(22.5%) and clopidogrel 21(16.93) were highly prescribed inappropriate medication followed by alprazolam8(6.45%), ipratropium bromide 7(5.64%), spironolactone 6(4.83%), ketorolac 4(3.22%), digoxin 3(2.4%), prazosin 3(2.4%), chloropheneramine maleate 3(2.4%), zolpidem 2(1.6%), lorazepam 2(1.6%), liquid paraffin2(1.6%), carbamazepine 2(1.6%), hydroxyzine 1(0.80), amitryptyline1(0.80) and amiodarone 1(0.80). In our study aspirin 28(22.5%) was the most commonly prescribed inappropriate drug in geriatric. The use of aspirin should be avoided as it may increase the risk of GI bleeding or peptic ulcer. The second most commonly prescribed inappropriate drug was clopidogrel 21(16.93%) along with aspirin which may increase the chances of stomach and intestinal bleeding. Alprazolam must be strictly avoided in geriatrics as it may increase the risk of cognitive impairment. Ipratropium bromide should be avoided in patients who have prostate enlargement and urinary tract problems as it may aggravate prostate problems and make urination difficult. Taking >25mg of spironolactone per day in heart failure patients may increase the risk of hyperkalemia. Ketorolac and etodolac may increase the risk of GI bleeding. Digoxin at doses higher than 0.125mg/day decreases its renal clearance which may lead to increased risk of toxicity. Acetylcholinesterase inhibitors such as prazosin should be avoided as it has increased risk of orthostatic hypotension or bradycardia. Chlorpheneramine maleate, hydroxyzine and triprolidine have potent cholinergic effects so it should be avoided because of its side-effects such as drowsiness, blurred vision, dry mouth, difficulty in urination and constipation. Zolpidem should be avoided in geriatrics as it may cause serious side effects such as confusions, falls, and bone fractures. In general benzodiazepines like lorazepam and clonazepam should be avoided in geriatrics as it has increased risk of cognitive impairement, delirium, falls and fractures. Liquid paraffin when swallowed, it may accidently get inhaled and cause pneumonia. Total number of  IM  1PIM  2PIM  3PIM  4PIM   60-69  68  692  51  16  8  5  1  70-79  42  461  44  12  8  4  1  80-89  9  75  3  1  1  -->90  5  50  2  2 ---
Figure 3
The study population of 124 cases was thoroughly evaluated for drug interactions with the help of Micromedex software available with the Department of Pharmacy Practice. The results of the drug interaction study revealed that 112(90%) prescriptions had drug interactions and 12(10%) prescriptions without drug interactions. From the 112 prescriptions we found that the average number of major interaction was 0.23 6.48 and moderate interaction was 1.97 2.156. Similar study by Akshaya B Srikanth et al (2012) [5] revealed that out of 103 patients 11.65% prescriptions was with drug interactions.
Study on severity of the drug interactions revealed that there were 28 drug interactions with major severity in 18 prescriptions and 257 moderate interactions in 94 prescriptions. Similarly Nimmy N John et al (2013) [8] observed that 20.1% were minor, 66.2% were moderate and 13.63 % were severe interactions.
The study shows that males 73 (58.9%) have used more drugs than females 51 (41.1%). In this case there is no significant association between the number of drugs taken and the age group between male and female. Males were prescribed with more drugs than females, but the difference between the genders is not significant. Males of age 70-79 years were taking more number of drugs in relation to other age groups of the same gender (p=0.065).Average number of drugs used by males (10.62  2.680) was higher than the average drugs used by females (9.96  2.735). Males had more major interactions (0.34  0.803) than females (0.06  0.238).This shows significant difference between the gender (p=0.016).
The association between various variables were obtained using SPSS. On assessment of association between "number of drugs" with "number of PIMs" , the result proved that "number of drugs" are statistically associated with the "number of PIMs" at 0.044 level of significance. This means that as the number of drugs increases, PIMs increases.
On assessment of association between "number of drugs" with "number of comorbidities" , the result proved that "number of drugs" are statistically associated with "number of comorbidities" at 0.002 level of significance. This result proves that comorbidity is one of the reasons for polypharmacy. This study demonstrated the need for professional attention and intervention by a clinical pharmacist to prevent and rectify problems due to polypharmacy in Geriatric population.Polypharmacy is most common among elderly patients. Various studies have shown that polypharmacy is related with negative health consequences and further research is required to describe the outcomes associated with avoidable drug use. Adherence to therapy, dosing & careful administration can be a problem among elders therefore; vigilant efforts should be done in order to determine adverse drug events predominantly due to metabolic & genetic susceptibility. Health care professionals must be aware of risks & benefits related to each prescribed medication. All medications for each patient should be fully evaluated by the health care professionals in order to avoid polypharmacy.
Future Scope
The study may be extended to geriatric patients whose renal and hepatic functions are critical. Further the quality of life studies may be carried out in consultation with occupational therapist. Furthermore there are lot of scope to assess in future studies the consequences of inappropriate prescribing according to Beer's criteria, such as comparing the risk of falls and fractures in patient groups with or without inappropriate drug use. Comparing outcome could give us an idea to what extend these criteria are relevant in clinical practice and influence the prognosis of older patients.
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